WO2020224605A1
|
|
Bcma-targeting engineered immune cell and use thereof
|
WO2020224606A1
|
|
Engineered immune cell targeting bcma and use thereof
|
WO2020151752A1
|
|
Engineered immune cells targeting cd20 combination
|
TW202100747A
|
|
Compositions and methods for immunotherapy
|
WO2020088631A1
|
|
Compositions and methods for t cell engineering
|
WO2019063018A1
|
|
Engineered immune cell having suicide gene switch and targeting human mesothelin
|
CN111133101A
|
|
Engineered immune cells capable of inducing secretion of anti-CD 47 antibody
|
WO2019047899A1
|
|
Universal chimeric antigen receptor t-cell preparation technique
|
CN110577604A
|
|
Chimeric antigen receptor T cell carrying GITR costimulatory signal targeting EGFR
|
CN110577932A
|
|
Chimeric antigen receptor T cell derived from umbilical cord blood
|
CN108424461A
|
|
CD47-CAR-T cells
|
CN110300603A
|
|
CD47-CAR-T cell
|